{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:07:02Z","timestamp":1787864822369,"version":"build-2784847793"},"reference-count":78,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009465","name":"\u201cCorporaci\u00f3n de Fomento de la Producci\u00f3n\u201d (CORFO)","doi-asserted-by":"publisher","award":["15COTE46282"],"award-info":[{"award-number":["15COTE46282"]}],"id":[{"id":"10.13039\/100009465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009465","name":"\u201cCorporaci\u00f3n de Fomento de la Producci\u00f3n\u201d (CORFO)","doi-asserted-by":"publisher","award":["12CTI-16838"],"award-info":[{"award-number":["12CTI-16838"]}],"id":[{"id":"10.13039\/100009465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Consumption of phytosterols is a nutritional strategy employed to reduce cholesterol absorption, but recent research shows that their biological activity might go beyond cholesterol reduction for the treatment of metabolic dysfunction-associated fatty liver disease (MAFLD), and novel phytosterol formulations, such as submicron dispersions, could improve these effects. We explored the therapeutic activity of phytosterols, either formulated as submicron dispersions of phytosterols (SDPs) or conventional phytosterol esters (PEs), in a mouse model of MAFLD. MAFLD was induced in mice by atherogenic diet (AD) feeding. The reversion of distorted serum and liver parameter values after a period of AD feeding was investigated after supplementation of the AD with SDPs, PEs, or a placebo (PT). Additionally, the metabolic parameters of fatty acid synthesis, fatty acid oxidation, and inflammation were studied to understand the mechanism of action of phytosterols. AD supplementation with SDPs was shown to reduce liver fat, along with showing a significant improvement in liver triglycerides (TGs), free fatty acids (FFAs), and liver cholesterol levels. These results were reinforced by the analyses of the liver steatosis scores, and liver histologies, where SDP intervention showed a consistent improvement. Treatment with PEs showed slighter effects in the same analyses, and no effects were observed with the PT treatment. Additionally, SDP intervention reversed, with a higher efficacy than PEs, the effect of AD on the serum levels of TGs, total- and LDL-cholesterol levels, and glucose levels. And, exceptionally, while SDP improved HDL-cholesterol serum levels, PEs did not show any effect on this parameter. We provide evidence for the therapeutical activity of phytosterols in MAFLD beyond the regulation of cholesterol levels, which is increased when the phytosterols are formulated as submicron dispersions compared to ester formulations.<\/jats:p>","DOI":"10.3390\/ijms26020564","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:24:42Z","timestamp":1736501082000},"page":"564","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Submicron Dispersions of Phytosterols Reverse Liver Steatosis with Higher Efficacy than Phytosterol Esters in a Diet Induced-Fatty Liver Murine Model"],"prefix":"10.3390","volume":"26","author":[{"given":"Raimundo","family":"Gillet","sequence":"first","affiliation":[{"name":"Naturalis Research Consortium, Santiago 8700548, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s G.","family":"Cerda-Drago","sequence":"additional","affiliation":[{"name":"Naturalis Research Consortium, Santiago 8700548, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Bra\u00f1es","sequence":"additional","affiliation":[{"name":"Naturalis Research Consortium, Santiago 8700548, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6142","authenticated-orcid":false,"given":"Rodrigo","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Faculty of Medicine, University of Chile, Santiago 8380000, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction\u2013associated fatty liver disease (MAFLD): An update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Flisiak-Jackiewicz, M., Bobrus-Chociej, A., Wasilewska, N., and Lebensztejn, D.M. (2021). From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)\u2014New Terminology in Pediatric Patients as a Step in Good Scientific Direction?. J. Clin. Med., 10.","DOI":"10.20944\/preprints202101.0516.v1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","article-title":"Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis","volume":"290","author":"Bradbury","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Drescher, H.K., Weiskirchen, S., and Weiskirchen, R. (2019). Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Cells, 8.","DOI":"10.3390\/cells8080845"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Brankovi\u0107, M., Jovanovi\u0107, I., Duki\u0107, M., Radonji\u0107, T., Opri\u0107, S., Kla\u0161nja, S., and Zdravkovi\u0107, M. (2022). Lipotoxicity as the leading cause of non-alcoholic steatohepatitis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095146"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut\u2013liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tarantino, G., Citro, V., and Capone, D. (2019). Nonalcoholic fatty liver disease: A challenge from mechanisms to therapy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010015"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"156028","DOI":"10.1016\/j.metabol.2024.156028","article-title":"The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus","volume":"161","author":"Zeng","year":"2024","journal-title":"Metabolism"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fujii, H., Kawada, N., and Japan Study Group of Nafld (JSG-NAFLD) (2020). The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113863"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105517","DOI":"10.1016\/j.phrs.2021.105517","article-title":"Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease","volume":"166","author":"Zhao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guirguis, E., Dougherty, J., Thornby, K., Grace, Y., and Mack, K. (2024). Resmetirom: The First Food and Drug Administration\u2013Approved Medication for Nonalcoholic Steatohepatitis (NASH). Ann. Pharmacother., 10600280241259528.","DOI":"10.1177\/10600280241259528"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Frasinariu, O., Serban, R., Trandafir, L.M., Miron, I., Starcea, M., Vasiliu, I., Alisi, A., and Temneanu, O.R. (2022). The role of phytosterols in nonalcoholic fatty liver disease. Nutrients, 14.","DOI":"10.3390\/nu14112187"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/lipd.12409","article-title":"Nuclear receptors behind the therapeutic effects of plant sterols on metabolism: A review","volume":"59","author":"Gillet","year":"2024","journal-title":"Lipids"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Song, L., Qu, D., Zhang, Q., Jiang, J., Zhou, H., Jiang, R., Li, Y., Zhang, Y., and Yan, H. (2017). Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet. Sci. Rep., 7.","DOI":"10.1038\/srep41604"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Plat, J., Hendrikx, T., Bieghs, V., Jeurissen, M.L., Walenbergh, S.M., van Gorp, P.J., De Smet, E., Konings, M., Vreugdenhil, A.C., and Guichot, Y.D. (2014). Protective role of plant sterol and stanol esters in liver inflammation: Insights from mice and humans. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110758"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jff.2014.12.046","article-title":"Flaxseed oil containing flaxseed oil ester of plant sterol attenuates high-fat diet-induced hepatic steatosis in apolipoprotein-E knockout mice","volume":"13","author":"Han","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Abo-Zaid, O.A., Moawed, F.S., Ismail, E.S., and Farrag, M.A. (2023). \u03b2-sitosterol attenuates high-fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway. BMC Pharmacol. Toxicol., 24.","DOI":"10.1186\/s40360-023-00671-0"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8294141","DOI":"10.1155\/2019\/8294141","article-title":"Plant Sterol Ester of \u03b1-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis","volume":"2019","author":"Han","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.tjnut.2023.05.026","article-title":"Stigmasterol protects against steatohepatitis induced by high-fat and high-cholesterol diet in mice by enhancing the alternative bile acid synthesis pathway","volume":"153","author":"Xin","year":"2023","journal-title":"J. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1039\/C9FO01570A","article-title":"The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/07315724.2018.1466739","article-title":"Effects of phytosterol supplementation on serum levels of lipid profiles, liver enzymes, inflammatory markers, adiponectin, and leptin in patients affected by nonalcoholic fatty liver disease: A double-blind, placebo-controlled, randomized clinical trial","volume":"37","author":"Javanmardi","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s12325-017-0580-1","article-title":"Short-term effects of a combined nutraceutical on lipid level, fatty liver biomarkers, hemodynamic parameters, and estimated cardiovascular disease risk: A double-blind, placebo-controlled randomized clinical trial","volume":"34","author":"Cicero","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1017\/S0007114520000495","article-title":"Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: A double-blind placebo-controlled clinical trial","volume":"123","author":"Song","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jff.2014.12.025","article-title":"Phytosterols increase circulating endothelial progenitor cells and insulin-like growth factor-1 levels in patients with nonalcoholic fatty liver disease: A randomized crossover study","volume":"13","author":"Chen","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bra\u00f1es, M.C., Gillet, R., and Valenzuela, R. (2023). Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030979"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jff.2013.10.017","article-title":"Water dispersible plant sterol formulation shows improved effect on lipid profile compared to plant sterol esters","volume":"6","author":"Shaghaghi","year":"2014","journal-title":"J. Funct. Foods"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Palmeiro-Silva, Y.K., Aravena, R.I., Ossio, L., and Parro Fluxa, J. (2020). Effects of daily consumption of an aqueous dispersion of free-phytosterols nanoparticles on individuals with metabolic syndrome: A randomised, double-blind, placebo-controlled clinical trial. Nutrients, 12.","DOI":"10.3390\/nu12082392"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterorol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep4.1765","article-title":"Poor awareness of liver disease among adults with NAFLD in the United States","volume":"5","author":"Alqahtani","year":"2021","journal-title":"Hepatol. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ghevariya, V., Sandar, N., Patel, K., Ghevariya, N., Shah, R., Aron, J., and Anand, S. (2014). Knowing what\u2019s out there: Awareness of non-alcoholic fatty liver disease. Front. Med., 1.","DOI":"10.3389\/fmed.2014.00004"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: A consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365520802588133","article-title":"Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol","volume":"44","author":"Yasutake","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tu, L.N., Showalter, M.R., Cajka, T., Fan, S., Pillai, V.V., Fiehn, O., and Selvaraj, V. (2017). Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-05040-6"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1080\/87559129.2023.2290489","article-title":"Metabolic Benefits of Phytosterols: Chemical, Nutritional, and Functional Aspects","volume":"40","author":"Bustamante","year":"2024","journal-title":"Food Rev. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07315724.2008.10719683","article-title":"The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations","volume":"27","author":"Naumann","year":"2008","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_43","first-page":"1143","article-title":"A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients","volume":"139","author":"Plat","year":"2009","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: A narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9150(99)00504-3","article-title":"Relationship of dietary fat to glucose metabolism","volume":"150","author":"Lichtenstein","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1753-0407.2010.00107.x","article-title":"Antidiabetic and antioxidant potential of \u03b2-sitosterol in streptozotocin-induced experimental hyperglycemia","volume":"3","author":"Gupta","year":"2011","journal-title":"J. Diabetes."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10616-020-00382-y","article-title":"Effect of \u03b2-sitosterol on glucose homeostasis by sensitization of insulin resistance via enhanced protein expression of PPR\u03b3 and glucose transporter 4 in high fat diet and streptozotocin-induced diabetic rats","volume":"72","author":"Ramalingam","year":"2020","journal-title":"Cytotechnology"},{"key":"ref_48","first-page":"224","article-title":"Antihyperglycemic and insulin-releasing effects of beta-sitosterol 3-beta-D-glucoside and its aglycone, beta-sitosterol","volume":"296","author":"Ivorra","year":"1988","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40200-020-00526-z","article-title":"Effects of Phytosterols supplementation on blood glucose, glycosylated hemoglobin (HbA1c) and insulin levels in humans: A systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Varkaneh","year":"2020","journal-title":"J. Diabetes. Metab. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/dia.2016.0103","article-title":"A phytosterol-enriched spread improves lipid profile and insulin resistance of women with gestational diabetes mellitus: A randomized, placebo-controlled double-blind clinical trial","volume":"18","author":"Li","year":"2016","journal-title":"Diabetes Technol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2016.01.035","article-title":"Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis","volume":"248","author":"Rocha","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_52","first-page":"709","article-title":"Mildly elevated liver transaminase levels: Causes and evaluation","volume":"96","author":"Oh","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2013.06.013","article-title":"Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar\u03b1)","volume":"714","author":"Shi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.78","article-title":"Carnitine palmitoyltransferase 1: Central to cell function","volume":"60","author":"Zammit","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal \u03b2-oxidation and peroxisome proliferator\u2013activated receptor \u03b1: An adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu. Rev. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399410001742","article-title":"Endoplasmic reticulum stress and lipid dysregulation","volume":"13","author":"Colgan","year":"2011","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jnutbio.2014.06.001","article-title":"Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1\/LKB1\/AMPK pathway","volume":"25","author":"Yang","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11745-004-1329-9","article-title":"Structure and function of animal fatty acid synthase","volume":"39","author":"Chirala","year":"2004","journal-title":"Lipids"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ma, Y., Lee, G., Heo, S.Y., and Roh, Y.S. (2021). Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease. Antioxidants, 11.","DOI":"10.3390\/antiox11010091"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.jhepr.2020.100101","article-title":"Combined alcoholic and non-alcoholic steatohepatitis","volume":"2","author":"Wandji","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Duan, Y., Pan, X., Luo, J., Xiao, X., Li, J., Bestman, P.L., and Luo, M. (2022). Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.880298"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bian, F., Yang, X.-Y., Xu, G., Zheng, T., and Jin, S. (2019). CRP-induced NLRP3 inflammasome activation increases LDL transcytosis across endothelial cells. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00040"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: Towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1080\/10408398.2021.1888692","article-title":"A review on chemical and physical modifications of phytosterols and their influence on bioavailability and safety","volume":"62","author":"Feng","year":"2022","journal-title":"Crit. Rev. Food. Sci. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","article-title":"Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs","volume":"12","author":"Vasconcelos","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1527-3466.2002.tb00096.x","article-title":"Sitosterolemia","volume":"20","author":"Salen","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5551\/jat.RV17052","article-title":"Diagnosis and management of sitosterolemia 2021","volume":"28","author":"Tada","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00394-016-1289-7","article-title":"Plasma fat-soluble vitamin and carotenoid concentrations after plant sterol and plant stanol consumption: A meta-analysis of randomized controlled trials","volume":"56","author":"Baumgartner","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1302\/0301-620X.64B5.6754741","article-title":"Vitamin D metabolism and its clinical application","volume":"64","author":"Kanis","year":"1982","journal-title":"J. Bone Jt. Surg. Br. Vol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nutres.2018.12.003","article-title":"Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL\/6J mice: Monitored by a novel quantitative ultrasound (QUS) method","volume":"63","author":"Han","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1039\/C5FO01086A","article-title":"Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Food Funct."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method","volume":"1","author":"Rahman","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1700479","DOI":"10.1002\/mnfr.201700479","article-title":"Supplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR-\u03b1 and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation","volume":"61","author":"Valenzuela","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1194\/jlr.M300190-JLR200","article-title":"Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue","volume":"44","author":"Zimmermann","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj1320509","article-title":"Insulin and the regulation of adipose-tissue acetyl-coenzyme A carboxylase","volume":"132","author":"Halestrap","year":"1973","journal-title":"Biochem. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/002215540205000208","article-title":"Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats","volume":"50","author":"Karlic","year":"2002","journal-title":"J. Histochem. Cytochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/2\/564\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:26:36Z","timestamp":1759919196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/2\/564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ijms26020564"],"URL":"https:\/\/doi.org\/10.3390\/ijms26020564","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}